Inhibikase Therapeutics

IKT

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-28.59M

EBITDA$-27.49M

EBIT$-27.52M

Pre-tax Income$-47.66M

Net Income$-27.52M

Net Cash$1.39B

Cash Equivalent$15.71M

Total Debt$293.14K

Net Debt$-1.39B

Book Value$26.55M

Net Cash Per Share10.57

Book Value Per Share1.21

Return on Equity (ROE)-29.01%

Return on Assets (ROA)-27.91%

Return on Invested Capital (ROI)-29.01%

Net Profit Margin-7304.75%

Current Ratio26.37

Quick Ratio26.13

Long-Term Debt / Equity0.00